+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Injectable Drug Delivery Market - Forecasts from 2019 to 2024

  • PDF Icon

    Report

  • 104 Pages
  • March 2019
  • Region: Global
  • Knowledge Sourcing Intelligence LLP
  • ID: 4766987
Injectable drug delivery is considered to be the most effective means of drug delivery into the human body and is thus considered to be the most effective administration route. These are in high demand due to the prevalence of chronic diseases worldwide driving the market growth during the forecast period. Furthermore, growing R&D activities, growing health expenditure and growing age-related diseases with the increasing elderly population worldwide are also driving the growth of the global injectable drug delivery market in the forecast period.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the injectable drug delivery value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the injectable drug delivery market.

Major industry players profiled as part of the report are Wilhelm Haselmeier GmbH & Co. KG, Owen Mumford Ltd, SHL Medical AG, Enable Injections, and Ypsomed AG.

Segmentation

The injectable drug delivery market has been analyzed through following segments:

By Device Type
Needle-free injectors
Patch injectors
Auto injectors
Others

By Application
Disease Treatment
Research/Academic purposes

By Geography
North America
USA
Canada
Mexico
Others

South America
Brazil
Argentina
Others

Europe
Germany
France
United Kingdom
Spain
Others

Middle East and Africa
Saudi Arabia
Israel
Others

Asia Pacific
China
Japan
South Korea
India
Others

Table of Contents

1. Introduction
1.1. Market Overview
1.2. Market Definition
1.3. Scope Of The Study
1.4. Currency
1.5. Assumptions
1.6. Base, And Forecast Years Timeline
2. Research Methodology
2.1. Research Design
2.2. Secondary Sources
3. Executive Summary
4. Market Dynamics
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter's Five Force Analysis
4.5.1. Bargaining Power Of Suppliers
4.5.2. Bargaining Power Of Buyers
4.5.3. Threat Of New Entrants
4.5.4. Threat Of Substitutes
4.5.5. Competitive Rivalry In The Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. Injectable Drug Delivery Market By Device Type
5.1. Needle-Free Injectors
5.2. Patch Injectors
5.3. Auto Injectors
5.4. Others
6. Injectable Drug Delivery Market By Application
6.1. Disease Treatment
6.2. Research/Academic Purposes
7. Injectable Drug Delivery Market By Geography
7.1. North America
7.1.1. USA
7.1.2. Canada
7.1.3. Mexico
7.1.4. Others
7.2. South America
7.2.1. Brazil
7.2.2. Argentina
7.2.3. Others
7.3. Europe
7.3.1. Germany
7.3.2. France
7.3.3. United Kingdom
7.3.4. Spain
7.3.5. Others
7.4. Middle East And Africa
7.4.1. Saudi Arabia
7.4.2. Israel
7.4.3. Others
7.5. Asia Pacific
7.5.1. China
7.5.2. Japan
7.5.3. South Korea
7.5.4. India
7.5.5. Others
8. Competitive Intelligence
8.1. Competitive Benchmarking And Analysis
8.2. Recent Investment And Deals
8.3. Strategies Of Key Players
9. Company Profiles
9.1. Wilhelm Haselmeier Gmbh & Co. Kg
9.2. Owen Mumford Ltd.
9.3. Shl Medical Ag
9.4. Enable Injections
9.5. Ypsomed Ag

Companies Mentioned

  • Wilhelm Haselmeier GmbH & Co. KG

  • Owen Mumford Ltd

  • SHL Medical AG

  • Enable Injections

  • Ypsomed AG

Methodology

Loading
LOADING...